144 related articles for article (PubMed ID: 38007156)
1. Effect of Automated and Personalized Outreach Messages on Well-Child Visit Catch Up: A Randomized Clinical Trial.
Berset AE; Burkhardt MC; Xu Y; Mescher A; Brinkman WB
Acad Pediatr; 2023 Nov; ():. PubMed ID: 38007156
[TBL] [Abstract][Full Text] [Related]
2. Effect of Electronic Outreach Using Patient Portal Messages on Well Child Care Visit Completion: A Randomized Clinical Trial.
Berset AE; Burkhardt MC; Xu Y; Mescher A; Brinkman WB
JAMA Netw Open; 2022 Nov; 5(11):e2242853. PubMed ID: 36399342
[TBL] [Abstract][Full Text] [Related]
3. Effect of Outreach Messages on Adolescent Well-Child Visits and Coronavirus Disease 2019 Vaccine Rates: A Randomized, Controlled Trial.
Burkhardt MC; Berset AE; Xu Y; Mescher A; Brinkman WB
J Pediatr; 2023 Feb; 253():158-164.e1. PubMed ID: 36202236
[TBL] [Abstract][Full Text] [Related]
4. Effect of Text Messaging and Behavioral Interventions on COVID-19 Vaccination Uptake: A Randomized Clinical Trial.
Mehta SJ; Mallozzi C; Shaw PA; Reitz C; McDonald C; Vandertuyn M; Balachandran M; Kopinsky M; Sevinc C; Johnson A; Ward R; Park SH; Snider CK; Rosin R; Asch DA
JAMA Netw Open; 2022 Jun; 5(6):e2216649. PubMed ID: 35696165
[TBL] [Abstract][Full Text] [Related]
5. Text message reminders for timely routine MMR vaccination: A randomized controlled trial.
Hofstetter AM; DuRivage N; Vargas CY; Camargo S; Vawdrey DK; Fisher A; Stockwell MS
Vaccine; 2015 Oct; 33(43):5741-5746. PubMed ID: 26424607
[TBL] [Abstract][Full Text] [Related]
6. Personalized Text Messages and Automated Calls for Improving Vaccine Coverage Among Children in Pakistan: Protocol for a Community-Based Cluster Randomized Clinical Trial.
Kazi AM; Ahsan N; Khan A; Jamal S; Kalimuddin H; Ghulamhussain N; Wajidali Z; Muqeet A; Zaidi F; Subzlani M; McKellin W; Ali A; Collet JP
JMIR Res Protoc; 2019 May; 8(5):e12851. PubMed ID: 31148544
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study.
Abu-Elyazeed R; Jennings W; Severance R; Noss M; Caplanusi A; Povey M; Henry O
Hum Vaccin Immunother; 2018; 14(11):2624-2631. PubMed ID: 29902133
[TBL] [Abstract][Full Text] [Related]
8. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
9. Effect of Training Pediatric Clinicians in Human Papillomavirus Communication Strategies on Human Papillomavirus Vaccination Rates: A Cluster Randomized Clinical Trial.
Szilagyi PG; Humiston SG; Stephens-Shields AJ; Localio R; Breck A; Kelly MK; Wright M; Grundmeier RW; Albertin C; Shone LP; Steffes J; Rand CM; Hannan C; Abney DE; McFarland G; Kominski GF; Seixas BV; Fiks AG
JAMA Pediatr; 2021 Sep; 175(9):901-910. PubMed ID: 34028494
[TBL] [Abstract][Full Text] [Related]
10. Improving Rates of Influenza Vaccination Through Electronic Health Record Portal Messages, Interactive Voice Recognition Calls and Patient-Enabled Electronic Health Record Updates: Protocol for a Randomized Controlled Trial.
Cutrona SL; Sreedhara M; Goff SL; Fisher LD; Preusse P; Jackson M; Sundaresan D; Garber LD; Mazor KM
JMIR Res Protoc; 2016 May; 5(2):e56. PubMed ID: 27153752
[TBL] [Abstract][Full Text] [Related]
11. Attitudinal and demographic predictors of measles-mumps-rubella vaccine (MMR) uptake during the UK catch-up campaign 2008-09: cross-sectional survey.
Brown K; Fraser G; Ramsay M; Shanley R; Cowley N; van Wijgerden J; Toff P; Falconer M; Hudson M; Green J; Kroll JS; Vincent C; Sevdalis N
PLoS One; 2011; 6(5):e19381. PubMed ID: 21602931
[TBL] [Abstract][Full Text] [Related]
12. Reducing geographic, racial, and ethnic disparities in childhood immunization rates by using reminder/recall interventions in urban primary care practices.
Szilagyi PG; Schaffer S; Shone L; Barth R; Humiston SG; Sandler M; Rodewald LE
Pediatrics; 2002 Nov; 110(5):e58. PubMed ID: 12415064
[TBL] [Abstract][Full Text] [Related]
13. Effect of Patient-Directed Messaging on Colorectal Cancer Screening: A Randomized Clinical Trial.
Oyalowo A; Forde KA; Lamanna A; Kochman ML
JAMA Netw Open; 2022 Mar; 5(3):e224529. PubMed ID: 35357457
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost-effectiveness of letters, automated telephone messages, or both for underimmunized children in a health maintenance organization.
Lieu TA; Capra AM; Makol J; Black SB; Shinefield HR
Pediatrics; 1998 Apr; 101(4):E3. PubMed ID: 9521970
[TBL] [Abstract][Full Text] [Related]
15. Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina.
Vizzotti C; Harris JB; Aquino A; Rancaño C; Biscayart C; Bonaventura R; Pontoriero A; Baumeister E; Freire MC; Magariños M; Duarte B; Grant G; Reef S; Laven J; Wannemuehler KA; Alvarez AMR; Staples JE
BMC Infect Dis; 2023 Mar; 23(1):165. PubMed ID: 36932346
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated With Opting Out of Automated Text and Telephone Messages Among Adult Members of an Integrated Health Care System.
Steiner JF; Zeng C; Comer AC; Barrow JC; Langer JN; Steffen DA; Steiner CA
JAMA Netw Open; 2021 Mar; 4(3):e213479. PubMed ID: 33769509
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for measles, mumps and rubella in children.
Demicheli V; Rivetti A; Debalini MG; Di Pietrantonj C
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD004407. PubMed ID: 22336803
[TBL] [Abstract][Full Text] [Related]
18. Effect of Electronic Portal Messaging With Embedded Asynchronous Care on Physician-Assisted Smoking Cessation Attempts: A Randomized Clinical Trial.
Erdmann M; Edwards B; Adewumi MT
JAMA Netw Open; 2022 Feb; 5(2):e220348. PubMed ID: 35226082
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial.
Lalwani S; Chatterjee S; Balasubramanian S; Bavdekar A; Mehta S; Datta S; Povey M; Henry O
BMJ Open; 2015 Sep; 5(9):e007202. PubMed ID: 26362659
[TBL] [Abstract][Full Text] [Related]
20. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
Saffar MJ; Fathpour GR; Parsaei MR; Ajami A; Khalilian AR; Shojaei J; Saffar H
J Trop Pediatr; 2011 Oct; 57(5):347-51. PubMed ID: 21078605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
